Prolonged efficacy of infliximab for refractory adult-onset Still's disease.

• Authors: M S Dilhuydy, R Vatan, G Etienne, M Longy-Boursier, P Mercié
• Journal: Clinical and experimental rheumatology (Clin Exp Rheumatol) 2005 Jan-Feb Vol. 23 Issue 1 Pg. 121-2 ISSN: 0392-856X [Print] Italy
• PMID: 15789901 (Publication Type: Case Reports, Letter)

Chemical References

• Antibodies, Monoclonal
• Antirheumatic Agents
• Tumor Necrosis Factor-alpha
• Infliximab

Topics

• Adult
• Antibodies, Monoclonal (therapeutic use)
• Antirheumatic Agents (therapeutic use)
• Female
• Humans
• Infliximab
• Still's Disease, Adult-Onset (drug therapy)
• Time Factors
• Treatment Outcome
• Tumor Necrosis Factor-alpha (antagonists & inhibitors)